Get the (AFMD) Report Here
Trade with Jim Cramer 14 Days FREE
AFMD has had better momentum than most biotechnology names.
DIS is a good value compared to most other big-cap names right now.
There are concerns that interest rates may start to impact new car sales.
A 27x trailing price-to-earnings ratio doesn't interest me.
Follow Real Money's Wall Street Pros to receive real-time investing alerts
Already a Subscriber? Login